Skip to main content
Premium Trial:

Request an Annual Quote

Blue Heron Receives NIH Grant for Universal Restriction Enzyme System Project

NEW YORK, Sept. 13 (GenomeWeb News) - Blue Heron Biotechnology said last week that it has received a phase I small business innovative research grant from the National Institutes of Health to develop a universal restriction enzyme system.

 

The grant, worth $137,910, was awarded by the National Institute of General Medical Science and the National Human Genome Research Institute, said Blue Heron.

 

According to the company, the goal of the grant project is to develop "a uniform method for assembling large DNA molecules by ligation of sticky-ended fragments, regardless of the sequence, the fragment length, or the presence of restriction sites." This method, Blue Heron said, is expected to allow the use of restriction digestion to release any cloned fragment and allow complete control of the sticky ends on these fragments.

 

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.